Jennifer L. Goralski

Statistics

Publications

Citations

795

H-Index

Active since

2014

Affiliations

University of North Carolina at Chapel Hill(Current)

University of Pittsburgh

Lung Institute

Imaging Center

University of Pennsylvania

Jennifer L. Goralski is an author at University of North Carolina at Chapel Hill specializing in cystic fibrosis, medicine, and cystic fibrosis pharmacotherapy.

ORCID

Publications per year

2014–2024

Publications

Phase 3 Open-Label Clinical Trial of Elexacaftor/Tezacaftor/Ivacaftor in Children Aged 2–5 Years with Cystic Fibrosis and at Least One F508del Allele

Jennifer L. Goralski, Jordana E. Hoppe, Marcus Mall et al. · American Journal of Respiratory and Critical Care Medicine · 2023 · 129 citations · Full text

Pharmacy, Pediatrics, Pharmacology +15

A non-BRICHOSSFTPCmutant (SP-CI73T) linked to interstitial lung disease promotes a late block in macroautophagy disrupting cellular proteostasis and mitophagy

Arie Hawkins, Susan H. Guttentag, Robin R. Deterding et al. · American Journal of Physiology-Lung Cellular and Molecular Physiology · 2014 · 93 citations · Full text

Life Sciences, Cell Biology, Molecular Biology +8

Elexacaftor-Tezacaftor- Ivacaftor improves sinonasal outcomes in cystic fibrosis

Amanda L. Stapleton, Adam J. Kimple, Jennifer L. Goralski et al. · Journal of Cystic Fibrosis · 2022 · 87 citations · Full text

Medicine, Otolaryngology, Pharmacotherapy +16

Reduction of Recurrence Risk of Pancreatitis in Cystic Fibrosis With Ivacaftor

Andres F. Carrion, Drucy Borowitz, Steven D. Freedman et al. · Journal of Pediatric Gastroenterology and Nutrition · 2017 · 73 citations

Medicine, Clinical Sciences, Pharmacotherapy +16

Worsening anxiety and depression after initiation of lumacaftor/ivacaftor combination therapy in adolescent females with cystic fibrosis

Cameron J. McKinzie, Jennifer L. Goralski, Terry L. Noah et al. · Journal of Cystic Fibrosis · 2017 · 66 citations

Medicine, Pharmacotherapy, Psychiatry +14

1–5 of 19